PIII vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PIII

50.2
AI Score
VS
PIII Wins

ASTH

49.3
AI Score

Investment Advisor Scores

PIII

50score
Recommendation
HOLD

ASTH

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PIII ASTH Winner
Revenue 772.77M 1.94B ASTH
Net Income 8.67M 34.17M ASTH
Net Margin 1.1% 1.8% ASTH
Operating Income 49.46M 62.85M ASTH
ROE 11.8% 4.1% PIII
ROA 1.3% 1.5% ASTH
Total Assets 654.39M 2.28B ASTH
Cash 21.27M 400.79M ASTH
Debt/Equity 1.64 1.06 ASTH
Current Ratio 0.46 1.23 ASTH

Relative Price Performance (Last 90 Days)

PIII 1M: -27.9% · 3M: -37.8% ASTH 1M: +6.1% · 3M: -4.7%

Current Technical Phase

PIII

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 35

RSI (14): 35.4 · Price: $8.43

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $37.98

Fundamentals Snapshot

Metric PIII ASTH
Market Cap
Forward P/E -0.6 10.7
Trailing P/E 46.4
Revenue (TTM)
Revenue Growth 0.1% 0.5%
Gross Margin 0.0% 0.1%
Operating Margin 0.1% 0.0%
EPS -32.47 0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PIII is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.